TOIIW
The Oncology Institute, Inc.
NASDAQ · Healthcare · Medical - Care Facilities · US
$0.05
−3.27%Aug 7, 2026, 18:05 UTC
Oncology Institute announced it has rebranded as Starling Oncology.
Source:Aug 7, 2026, 00:13 UTC
The Oncology Institute, Inc. reported a second-quarter loss of $0.08 per share, which was larger than the Zacks Consensus Estimate of a $0.07 loss but improved from a $0.14 loss a year earlier.
Source:Jul 7, 2026, 13:00 UTC
The Oncology Institute repaid its $86 million senior secured convertible note with Deerfield Partners through a refinancing that includes new credit facilities from OrbiMed.
Source:Jul 7, 2026, 00:00 UTC
Oncology Institute, Inc. issued warrants exercisable for 10,025,535 shares of its common stock to Deerfield Partners, L.P. and affiliates, with an initial exercise price of $8.567 per share and expiration on August 9, 2027.